Skip to content

Controlled MAP in the Brain Injury Patient (COMAT Study)

Controlled Mean Arterial Pressure of Brain Injury Patients Using an Novel Automated System for Vasopressor Administration : a Randomized Controlled Trial in Critically Ill Patients in the Intensive Care Unit

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03991052
Acronym
COMAT
Enrollment
23
Registered
2019-06-19
Start date
2019-12-18
Completion date
2021-07-07
Last updated
2023-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injuries

Brief summary

The goal of this randomized controlled trial will be to show that the use of a novel automated system to guide vasopressor administration in brain injury patients will results in more time spent with a mean arterial pressure (MAP) within the predefined MAP (+/- 5 mmHg of the target MAP) compared to patients managed without any automated system (manually management)

Detailed description

In brain injury patients, the maintenance of MAP within a very narrow range is desired to avoid complications related to hypoperfusion (undertreatment) or hypertension (over treatment). However, the MAP needed to reach can vary over time based on intracranial pressure. Additionally, it is well know that the nurses in the Intensive care unit managed multiple patients simultaneously and cannot dedicate 100% of his-her time to adjust drugs infusions. Using a novel automated system can overcome this issue and may lead to more time in MAP target (+/- 5mmHg) than the traditional management. After initial rescuscitation of the patients, patients in both groups will have the same baseline maintenance fluid administration of 1-2 ml/kg/h of crystalloid solution and additionnal fluid boluses administered following the EV1000 monitoring device. The only difference will be the management of vasopressor titration (manual by nurses vs automated via a closed-loop system)

Interventions

This system will recommend when patients need fluid or not and adjust vasopressor administration automatically by the closed-loop system

DEVICEControl group

This system will recommend when patients need fluid or not and nurses will adjust vasopressor administration as usual (standard of care)

Sponsors

University of California, Los Angeles
CollaboratorOTHER
University of California, Irvine
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

manual versus automated management of MAP

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* severe brain injury patients (Glasgow score \<9), intubated, ventilated and sedated.

Exclusion criteria

* Glasgow score \> 8 * Bilateral mydriasis at the initial management (Ambulance and first hour of arrival)

Design outcomes

Primary

MeasureTime frameDescription
Mean arterial pressure (MAP)48 hours post-admission in the intensive care unitpercentage of treatment time when MAP will be in the predefined range (+/- 5 mmHg of the target MAP)

Secondary

MeasureTime frameDescription
Percentage of case time spent in Hypotension48 hours post-admission in the intensive care unitpercentage time spent with MAP below 5 mmHg of the predefined MAP
Percentage of case time spent Hypertension48 hours post-admission in the intensive care unitpercentage time spent with MAP above 5 mmHg of the predefined MAP
Cerebral perfusion pressure48 hours post-admission in the intensive care unitMeasure of Cerebral perfusion pressure during the treatment time (evolution of Cerebral perfusion pressure over time)
Intracranial pressure48 hours post-admission in the intensive care unitMeasure of intracranial pressure during the treatment time (evolution over time)
Intracranial pressure Hypertension48 hours post-admission in the intensive care unitpercentage of intracranial pressure over 20 mmHg during the treatment period
stroke volume48 hours post-admission in the intensive care unitstroke volume over the treatment period
Amount of vasopressor48 hours post-admission in the intensive care unitamount of vasopressor received during the treatment period
Length of stay in the intensive care unit30 days post-admission in the intensive care unitcomparison of the length of stay in the intensive care unit between both groups.
mean arterial pressure (MAP)48 hours post-admission in the intensive care unitMAP over the treatment period
cardiac index48 hours post-admission in the intensive care unitcardiac index over the treatment period. This will be the mean values over the procedure. Measurements recorded each 20 seconds and averaged for the procedure. The unit is l/min/m-2
Transcranial doppler48 hours post-admission in the intensive care unitmeasure of mean cerebral velocity of mean cerebral artery
Fluid received48 hours post-admission in the intensive care unitcomparison of amount of fluid received during the treatment period

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026